Health Care Blog November 10, 2021
Jessica DaMassa, WTFHealth

The same day Walgreens announced its $5.2B investment in VillageMD to snag a majority stake in the growing primary care clinic, it ALSO revealed it had made a $300M investment in CareCentrix that scored 55% of that company and another opportunity to expand its reach beyond the pharmacy – this time into the home.

CareCentrix’s CEO John Driscoll takes us behind the deal, which lands Walgreens into the world of post-acute care (home nursing, hospital discharge recovery, home infusion, palliative care, etc.) which he describes as the “long-form sexy-cool” segment of the healthcare market that’s not only worth $75B annually now, but that’s also set for massive growth over the next 20 years.

Walgreens is clearly seeing the opportunity John’s...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Investments, Pharma, Pharma / Biotech, Post-Acute Care, Provider, Retail care, Trends
Private equity firm to buy Walgreens for $10B, report says
Podcast: Jihye Han Compares First-In-Class Drug Regulation in the US and Europe
Enhancing primary care: The impact of pharmacist-led chronic care and AI-driven telehealth
Why Walgreens Specialty Pharmacy May Be Its Most Desirable Asset
Pharma Pulse 3/3/25: Will Tariffs Affect Branded Drug Prices? Pharmacists' Role in Medical Cannabis Counseling and Patient Education & more

Share This Article